狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            BPS Bioscience Inc.
            中級(jí)會(huì)員 | 第3年

            13829799985

            當(dāng)前位置:BPS Bioscience Inc.>>試劑>>藥物篩選>> SRT1720

            SRT1720

            參  考  價(jià)面議
            具體成交價(jià)以合同協(xié)議為準(zhǔn)

            產(chǎn)品型號(hào)

            品       牌BPS Bioscience

            廠商性質(zhì)生產(chǎn)商

            所  在  地

            更新時(shí)間:2024-11-23 08:57:04瀏覽次數(shù):216次

            聯(lián)系我時(shí),請告知來自 化工儀器網(wǎng)
            同類優(yōu)質(zhì)產(chǎn)品更多>
            保存條件:Roomtemp
            • 保存條件:

              Room temp. (continental US) or gel packs

            • 保質(zhì)期:

              Store at or below -20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.

            • 英文名:

              SRT1720

            • 數(shù)量:

              1

            • 供應(yīng)商:

              BPS Bioscience Inc.

            • CAS號(hào):

              /

            • 規(guī)格:

              5 mg

            SRT1720 is a small-molecule compound which has the ability of activating the sirtuin subtype SIRT1 in vitro. SRT1720 has similar activity in the body to the known SIRT1 activator resveratrol, but is 1000x more potent. It affects mitochondrial respiration in a Sirt1- and PGC-1α-dependent manner. SRT1720 has been demonstrated to enhance insulin sensitivity and improve measures of mitochondrial capacity and oxidative metabolism. Treatment of multiple myeloma (MM) cells with SRT1720 inhibits growth and induced apoptosis in MM cells resistant to conventional and bortezomib therapies without significantly affecting the viability of normal cells. SRT1720 is able to enhance the cytotoxic activity of bortezomib or dexamethasone. Anti-MM activity of SRT1720 is related to: 1) activation of caspase-8, caspase-9, caspase-3, poly(ADP) ribose polymerase; 2) increase in reactive oxygen species; 3) induction of phosphorylated ataxia telangiectasia mutated/checkpoint kinase 2 signaling; 4) decrease in vascular endothelial growth factor-induced migration of MM cells and associated angiogenesis; and 5) inhibition of nuclear factor-κB.
            溫馨提示:不可用于臨床治療。

            會(huì)員登錄

            ×

            請輸入賬號(hào)

            請輸入密碼

            =

            請輸驗(yàn)證碼

            收藏該商鋪

            X
            該信息已收藏!
            標(biāo)簽:
            保存成功

            (空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)

            常用:

            提示

            X
            您的留言已提交成功!我們將在第一時(shí)間回復(fù)您~
            撥打電話
            在線留言